By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid today announced it has received clearance from the US Food and Drug Administration to market its Xpert SA Nasal Complete.

The test is the only molecular diagnostic product designed for the detection and differentiation of Staphylococcus aureas and Methicillin-resistant Staphylococccus aureus colonization in under one hour, Cepheid said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.